Definitive Healthcare Corp. (DH)
After hours:
| Previous Close | 7.33 |
| Open | 7.30 |
| Bid | 7.26 x 100 |
| Ask | 7.29 x 100 |
| Day's Range | 7.24 - 7.57 |
| 52 Week Range | 5.53 - 12.45 |
| Volume | |
| Avg. Volume | 524,538 |
| Market Cap | 856.326M |
| Beta (5Y Monthly) | 1.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.79 |
| Earnings Date | May 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.40 |
GlobeNewswireDefinitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2024, on Tuesday, May 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event will be available
- GlobeNewswire
Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry
Medtech commercial teams can now solve frontline sales challenges with exceptional data and streamlined workflowsFRAMINGHAM, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the launch of Carevoyance, an innovative sales enablement solution tailored for medtech organizations. Acquired by Definitive Healthcare in January 2024, Carevoyance tackles frontline sales challenges head-on. It’s a powerf
- GlobeNewswire
VML and Definitive Healthcare announce partnership to transform key opinion leader management
Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversationsFRAMINGHAM, Mass. and LONDON, March 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH) and VML Health announced a first-of-its-kind partnership that gives clients the ability to manage their entire key opinion leader (KOL) identification and engagement operation from an integrated solution. This partnership provides
